Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in VCEL — Vericel Corp

CIK 948046 FRANKFURT AM MAIN, 2M
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,865,332
+$1,034,894 QoQ
Shares Held
64,404
+13.2% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. VCEL ranks #92 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,865,332 64,404
2026-03-31 $1,830,438 56,899
2025-12-31 $1,854,009 51,486
2025-09-30 $1,551,028 49,286
2025-06-30 $1,899,090 44,632
2025-03-31 $2,120,966 47,534
2024-12-31 $2,910,173 52,999
2024-09-30 $1,694,604 40,109
2024-06-30 $1,479,078 32,238
2024-03-31 $1,831,830 35,214
2023-12-31 $1,239,012 34,794
2023-09-30 $1,199,912 35,797
2023-06-30 $1,133,298 30,165
2023-03-31 $1,235,485 42,138
2022-12-31 $840,086 31,894
2022-09-30 $528,240 22,769
2022-06-30 $658,808 26,164
2022-03-31 $1,127,909 29,511
2021-12-31 $1,263,611 32,153
2021-09-30 $1,519,971 31,147
2021-06-30 $2,814,735 53,614
2021-03-31 $6,601,949 118,847
2020-12-31 $1,103,496 35,735
2020-09-30 $1,065,900 57,523
2020-06-30 $812,435 58,787
2020-03-31 $164,546 17,944